[HTML][HTML] Mechanisms of SARS-CoV-2 entry into cells
The unprecedented public health and economic impact of the COVID-19 pandemic caused
by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been …
by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been …
The biological and clinical significance of emerging SARS-CoV-2 variants
The past several months have witnessed the emergence of SARS-CoV-2 variants with novel
spike protein mutations that are influencing the epidemiological and clinical aspects of the …
spike protein mutations that are influencing the epidemiological and clinical aspects of the …
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
During the current coronavirus disease 2019 (COVID-19) pandemic, a variety of mutations
have accumulated in the viral genome of severe acute respiratory syndrome coronavirus 2 …
have accumulated in the viral genome of severe acute respiratory syndrome coronavirus 2 …
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
Summary Background Several SARS-CoV-2 variants of concern have been identified that
partly escape serum neutralisation elicited by current vaccines. Studies have also shown …
partly escape serum neutralisation elicited by current vaccines. Studies have also shown …
[HTML][HTML] Effectiveness of a third dose of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations …
MG Thompson - MMWR. Morbidity and mortality weekly report, 2022 - cdc.gov
VE was significantly higher among patients who received their second mRNA COVID-19
vaccine dose< 180 days before medical encounters compared with those vaccinated≥ 180 …
vaccine dose< 180 days before medical encounters compared with those vaccinated≥ 180 …
Waning immunity after the BNT162b2 vaccine in Israel
Abstract Background In December 2020, Israel began a mass vaccination campaign against
coronavirus disease 2019 (Covid-19) by administering the BNT162b2 vaccine, which led to …
coronavirus disease 2019 (Covid-19) by administering the BNT162b2 vaccine, which led to …
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape
JS Tregoning, KE Flight, SL Higham, Z Wang… - Nature reviews …, 2021 - nature.com
Where 2020 saw the development and testing of vaccines against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) at an unprecedented pace, the first half of 2021 has …
syndrome coronavirus 2 (SARS-CoV-2) at an unprecedented pace, the first half of 2021 has …
Protection of BNT162b2 vaccine booster against Covid-19 in Israel
Abstract Background On July 30, 2021, the administration of a third (booster) dose of the
BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) was approved in Israel for persons …
BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) was approved in Israel for persons …
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
D Planas, D Veyer, A Baidaliuk, I Staropoli… - Nature, 2021 - nature.com
Abstract The SARS-CoV-2 B. 1.617 lineage was identified in October 2020 in India,,,–. Since
then, it has become dominant in some regions of India and in the UK, and has spread to …
then, it has become dominant in some regions of India and in the UK, and has spread to …
Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study
J Hippisley-Cox, CAC Coupland, N Mehta, RH Keogh… - bmj, 2021 - bmj.com
Objectives To derive and validate risk prediction algorithms to estimate the risk of covid-19
related mortality and hospital admission in UK adults after one or two doses of covid-19 …
related mortality and hospital admission in UK adults after one or two doses of covid-19 …